BOT 14.3% 40.0¢ botanix pharmaceuticals ltd

Ann: FDA Approves Sofdra, page-98

  1. 1,678 Posts.
    lightbulb Created with Sketch. 45
    Officially huge congrats to each one of the BOT holders with a slightest of dampener on the enthusiasm expressed by many over the last 2-3 weeks. . Not the ideal way to do CR but hey look at DXB.

    FDA stamp is a huge tick going forward and the much needed outcome for the shareholders who were left frustrated late last year.

    Hoping CR is not at a some ridiclous discount. Well done & good luck and hope you can all multiply your wealth in coming quarters


 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
0.050(14.3%)
Mkt cap ! $724.0M
Open High Low Value Volume
35.5¢ 40.0¢ 35.5¢ $6.075M 15.87M

Buyers (Bids)

No. Vol. Price($)
5 287187 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 1920397 33
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.